Network News

Study demonstrates the ability of small RNA to inform lung cancer treatment strategies HEIDELBERG, Germany, October 26, 2026 – Hummingbird Diagnostics GmbH, a pioneer in blood-based small RNA biomarker discovery and assay development, today announced new clinical data demonstrating the ability of small RNA to enable adaptive treatment strategies in lung cancer patients. The results […]

Informationen über unsere Aktivitäten und aktuelle Entwicklungen im Biobanking am Standort und darüber hinaus. IN DIESER AUSGABE__Die BMBH im ÜberblickAktuelles aus der BMBHAktuelles aus denMitgliedsbiobankenNationale / InternationaleBiobanking-AktivitätenPublikationenAnstehende Termine

After almost 20 years, Professor Dr. Andreas von Deimling has handed over leadership of Neuropathology at Heidelberg University Hospital to Professor Dr. Dr. Felix Sahm. When Andreas von Deimling was appointed W3 Professor of Neuropathology in 2007, Heidelberg Faculty of Medicine at Heidelberg University, together with the German Cancer Research Center (DKFZ), pursued a strategic […]

Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany Paris and Frankfurt, October 19, 2026. Sanofi today broke ground on a new state-of-the-art insulin manufacturing facility at its BioCampus in Frankfurt, Germany. The new facility will bring a new generation of insulin production to one of Sanofi’s largest integrated research and manufacturing sites, […]

A European research consortium led by the German Cancer Research Center (DKFZ) aims to fundamentally improve the diagnosis and treatment of prostate cancer using AI agents, big data, and patient-centered clinical decision support. The central goal is to detect aggressive tumors early and accurately, reduce unnecessary interventions, and tailor treatment decisions more closely to the […]

Danvers, MA, USA, October 7, 2026–Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced the availability for purchase of GMP-grade recombinant monoclonal antibody conjugates targeting the G4S linker of scFv-based chimeric antigen receptors (CARs) for CAR-T cell enrichment and detection in cell therapy manufacturing […]

The Wittenstein Biointelligence Prize was awarded on Tuesday evening at the third Biointelligence Congress. Biotechnologist Moritz Bross won in the “Individual” category, while Cortical Labs was honored in the “Company” category. With this prize, the Wittenstein Foundation recognizes innovative, practical, and sustainable solutions that combine biology with information and production technology. Full Text in German […]

Horizon Europe funding will support GENCODE, UniProt, and Europe PMC The European Commission has announced €57 million in funding to support GENCODE, UniProt, and Europe PMC. These life sciences data resources are delivered and managed by EMBL’s European Bioinformatics Institute (EMBL-EBI) alongside international partners. The financial support will be given in the shape of three […]

How can cell-based immunotherapies for cancer and autoimmune diseases become more widely available in the long term? The SYNTHIA project is addressing this challenge: The Max Planck Institute for Medical Research and the Fraunhofer Institute for Cell Therapy and Immunology IZI are collaborating on new research approaches to advance the development of cell-based immunotherapies. The […]